Orchestra BioMed Holdings, Inc. Depreciation
Orchestra BioMed Holdings, Inc. (OBIO) reported Depreciation of $327.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-12
- Orchestra BioMed Holdings, Inc. depreciation for the quarter ending 2025-12-31 was $82.00K, a 2.38% decline year-over-year.
- Orchestra BioMed Holdings, Inc. depreciation for the quarter ending 2025-09-30 was $81.00K, a 6.58% increase year-over-year.
- Orchestra BioMed Holdings, Inc. depreciation for the quarter ending 2025-06-30 was $81.00K, a 9.46% increase year-over-year.
- Orchestra BioMed Holdings, Inc. depreciation for the quarter ending 2025-03-31 was $83.00K, a 12.16% increase year-over-year.
- Orchestra BioMed Holdings, Inc. depreciation for fiscal 2025 was $327.00K, a 6.17% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. depreciation for fiscal 2024 was $308.00K, a 7.32% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. depreciation for fiscal 2023 was $287.00K, a 29.28% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. depreciation for fiscal 2022 was $222.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $163.00K derived: sum of 2 quarters · filed 2026-03-12 | $244.00K derived: sum of 3 quarters · filed 2026-03-12 | $327.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $81.00K 10-Q · filed 2025-11-10 | $162.00K derived: sum of 2 quarters · filed 2025-11-10 | $245.00K 10-Q · filed 2025-11-10 | $329.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $81.00K 10-Q · filed 2025-08-12 | $164.00K 10-Q · filed 2025-08-12 | $248.00K derived: sum of 3 quarters · filed 2026-03-12 | $324.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $83.00K 10-Q · filed 2025-05-12 | $167.00K derived: sum of 2 quarters · filed 2026-03-12 | $243.00K derived: sum of 3 quarters · filed 2026-03-12 | $317.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $160.00K derived: sum of 2 quarters · filed 2026-03-12 | $234.00K derived: sum of 3 quarters · filed 2026-03-12 | $308.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $76.00K 10-Q · filed 2025-11-10 | $150.00K derived: sum of 2 quarters · filed 2025-11-10 | $224.00K 10-Q · filed 2025-11-10 | $296.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $74.00K 10-Q · filed 2025-08-12 | $148.00K 10-Q · filed 2025-08-12 | $220.00K derived: sum of 3 quarters · filed 2025-08-12 | $291.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $74.00K 10-Q · filed 2025-05-12 | $146.00K derived: sum of 2 quarters · filed 2025-05-12 | $217.00K derived: sum of 3 quarters · filed 2025-05-12 | $289.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $143.00K derived: sum of 2 quarters · filed 2025-03-31 | $215.00K derived: sum of 3 quarters · filed 2025-03-31 | $287.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $71.00K 10-Q · filed 2024-11-12 | $143.00K derived: sum of 2 quarters · filed 2024-11-12 | $215.00K 10-Q · filed 2024-11-12 | $284.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $72.00K 10-Q · filed 2024-08-12 | $144.00K 10-Q · filed 2024-08-12 | $213.00K derived: sum of 3 quarters · filed 2024-08-12 | $267.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $71.00K 10-Q · filed 2024-05-13 | $141.00K derived: sum of 2 quarters · filed 2024-05-13 | $195.00K derived: sum of 3 quarters · filed 2024-05-13 | $244.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $124.00K derived: sum of 2 quarters · filed 2024-03-27 | $173.00K derived: sum of 3 quarters · filed 2024-03-27 | $222.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $54.00K 10-Q · filed 2023-11-13 | $103.00K derived: sum of 2 quarters · filed 2023-11-13 | $152.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $49.00K 10-Q · filed 2023-08-10 | $98.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $48.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |